ArticleBMC pregnancy and childbirth2026
Establishment of biological reference intervals for coagulation indicators in pregnancy using a non-parametric approach.
Article in BMC pregnancy and childbirth, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
backgroundThis study aimed to evaluate changes in activated partial thromboplastin time (APTT), prothrombin time (PT), thrombin time (TT), and fibrinogen (FIB), and D-dimer (DD) levels during different trimesters of pregnancy in healthy pregnant women. The objective was to establish trimester-specific reference intervals for these coagulation parameters using the non-parametric percentile method as recommended by the Clinical and Laboratory Standards Institute (CLSI) C28-A3 guideline, thereby providing a basis for accurate clinical assessment of coagulation status during pregnancy.
methodsA total of 2,657 healthy pregnant women were selected from Sichuan JinxinXinan Women and Children Hospital from January 2024 to December 2024. Of these women, 646 were included in the first-trimester group; 1,128 were included in the second-trimester group; and 883 were included in the third-trimester group. In addition,198 healthy non-pregnant women were included in the control group. The coagulation indicators of each group were detected and analyzed, and differences in these indicators across different age groups were assessed. Following the CLSI C28-A3 guidelines, reference intervals were established using the non-parametric percentile method (P
resultsNo significant differences were observed in any coagulation indicators between pregnant women aged < 30 years and those aged ≥ 30 years in the first-, second-, and third-trimester groups(P > 0.01).APTT, PT, and TT decreased with the advancement of gestational age, and the differences between the periods of each gestation were statistically significant (P < 0.01).FIB and DD levels increased with the advancement of gestational age, and the differences were statistically significant between each trimester(P < 0.01).The established reference intervals for the first trimester were: APTT 25.20-36.48 s, PT 11.10-13.00 s, TT 15.00-17.70 s, FIB 2.58-5.04 g/L, and DD ≤ 1.11 µg/mL. For the second trimester: APTT 24.40-34.56 s, PT 10.90-12.60 s, TT 14.70-17.20 s, FIB 2.95-5.27 g/L, and DD ≤ 2.94 µg/mL. For the third trimester: APTT 24.70-33.40 s, PT 10.60-12.40 s, TT 14.60-16.80 s, FIB 3.39-5.90 g/L, and DD ≤ 4.62 µg/mL. Compared with previously published reference intervals from other populations, our findings show similar trends but with notable differences in absolute values, particularly for FIB and DD, which may be attributed to geographical and ethnic variations. The biological reference intervals of all five coagulation indicators were successfully validated.
conclusionTrimester-specific reference intervals were successfully established for five coagulation indicators using the non-parametric approach recommended by CLSI C28-A3. These intervals provide a crucial tool for accurate clinical diagnosis and prevention of coagulation disorders during pregnancy, potentially reducing misdiagnosis and unnecessary interventions associated with using non-pregnancy reference intervals. However, multicenter validation studies are needed to confirm the generalizability of these findings to other populations.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.